The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...

Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.

U.S. Enters a New Political Era, Defined by Donald Trump The presidential race in 2012 ended a pattern in U.S. politics, which has since become characterized by Mr. Trump’s populism, a Times ...

Footage shows heavy smoke engulfing the cabin on the Swiss airlines flight from Bucharest, Romania, to Zurich, Switzerland, on Monday evening. The smoke in the cabin and cockpit reportedly ...

A Visit from St. Nicholas Rodgers open to pay cut but unsure about playing next season Asking Eric Today’s horoscope ...